Zydus Lifesciences receives USFDA approval to market a generic medication for multiple sclerosis, a generic version of ...

Zydus Lifesciences said that it has has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose ...

National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of 0.5ML Autodisable Syringes manufactured by Afrimedical Manufacturing and Supplies Limited, Ibafo, Ogun ...

Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April ...

Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 ...

Biocon Biologics secures multiple market access agreements in the US for its biosimilar, Yesintek, for treating Crohn's ...

Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis ...

What you need to know Adrenal insufficiency is the inadequate production of the hormone cortisol from the adrenal glands. Global prevalence ranges from 0.4/100 000 (South Korea) to 15-22/100 000 ...

CEO Roberty Hayes noted that the order represents a transformative moment for Sharps Technology as it begins generating ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of ...

In fact, each Revok50 syringe contains 50 mg of HA with a molecular weight of ... and larger aliquots of about 0.1 mL per ...